Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented at IUIS bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.
16 November 2023 - Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that an abstract highlighting the potential o.
This time last year, we wrote about a long-overlooked FDA statutory authority and wondered if this provision, known colloquially as the "single study plus confirmatory evidence" pathway.